candesartan has been researched along with estradiol 3-benzoate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guerra, MJ; Labandeira-Garcia, JL; Rodriguez-Perez, AI; Valenzuela, R; Villar-Cheda, B | 1 |
1 other study(ies) available for candesartan and estradiol 3-benzoate
| Article | Year |
|---|---|
Dopaminergic neuroprotection of hormonal replacement therapy in young and aged menopausal rats: role of the brain angiotensin system.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Corpus Striatum; Dopaminergic Neurons; Estradiol; Estrogen Replacement Therapy; Female; Nerve Degeneration; Neuroprotective Agents; Ovariectomy; Oxidopamine; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles | 2012 |